Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA
Clearance Recognises CellDx-Tissue's Dual-Analyte DNA and RNA Workflow Across 517 Cancer-Associated Genes, with ALK, RET and ROS1 Fusion Calls on RNA-Level Evidence NASHIK, India, May 14, 2026 /PRNewswire/ -- Datar Cancer Genetics (DCG), a global...
Kelun-Biotech Receives Investigational New Drug Approval from CDE for SKB118, a PD-1 x VEGF Bispecific Antibody
CHENGDU, China, May 12, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that it has received a clinical trial notice from the Center for Drug Evaluation (CDE) of the...
Avance Clinical Receives Frost & Sullivan's 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership
The company is recognized for its innovation, scientific expertise, and customer-centric clinical development model in the global biotechnology CRO market SAN ANTONIO, May 12, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that...
ScienceSoft Receives Frost & Sullivan's 2025 North America Enabling Technology Leadership Recognition for Advancing Patient Engagement and Telehealth Innovation
ScienceSoft is recognized for enabling real-time patient engagement through AI-driven conversational technologies that streamline telehealth operations and enhance care delivery. SAN ANTONIO, May 12, 2026 /PRNewswire/ -- Frost & Sullivan is...
World's First | Mabwell's 9MW5211 Receives FDA Clearance for Clinical Trial Application
SHANGHAI, May 9, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Investigational New Drug (IND) application for 9MW5211, its independently...
CL Workshop Group Limited Receives Nasdaq Notice of Bid Price Deficiency
NEW YORK, May 8, 2026 /PRNewswire/ -- CL Workshop Group Limited (Nasdaq: NWGL) (the "Company"), a global forestry company that focuses on the timber and wood products industry, today announced that it received a notification letter dated May 6, 2026...
AeC Receives Frost & Sullivan's 2026 Brazilian Customer Experience Management Company of the Year Recognition
Recognized for its visionary innovation and disciplined growth, delivering exceptional customer satisfaction and operational excellence in Brazil's evolving landscape. SAN ANTONIO, May 7, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to...
BostonGene Receives Frost & Sullivan's 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms
Recognition highlights BostonGene's leadership in improving drug development decisions, reducing risk and accelerating patient impact SAN ANTONIO, May 5, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that BostonGene has been...
Insilico's Rentosertib Inhalation Solution Receives IND Clearance for the World's First AI-Driven Candidate to Enter Direct-to-Lung Clinical Study
Following positive Phase IIa results for oral Rentosertib in GENESIS-IPF with good tolerability, a favorable PK profile, and dose-dependent efficacy improvements, the inhalation solution has received IND clearance from the CDE. The inhalation...
C-Ray Therapeutics Receives FDA Acceptance of Type II Drug Master File for Copper-64 (Cu-64)
DMF No. 43568 is now active and available for reference in global IND and NDA submissions CHENGDU, China, April 28, 2026 /PRNewswire/ -- C-Ray Therapeutics (Chengdu) Co., Ltd., today announced that its Type II Drug Master File (DMF) for COPPER...